Wieczorek, Maud
Schwarz, Franziska
Sadlon, Angélique
Abderhalden, Lauren A.
de Godoi Rezende Costa Molino, Caroline
Spahn, Donat R.
Schaer, Dominik J.
Orav, E. John
Egli, Andreas
Bischoff-Ferrari, Heike A. http://orcid.org/0000-0002-4554-658X
,
Funding for this research was provided by:
Vifor Pharma
European Commission (Grant Agreement n°278588)
Universität Zürich
DNP
Roche
NESTEC
Pfizer
Streuli
Universität Zürich
Article History
Received: 3 June 2021
Accepted: 3 August 2021
First Online: 17 September 2021
Declarations
:
: LA is currently an employee of MSD, Switzerland. <b>DRS</b> reports personal fees from Danube University of Krems, US Department of Defense, European Society of Anesthesiology, Korean Society for Patient Blood Management, Korean Society of Anesthesiologists, Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis, Bayer AG, Zürich, B. Braun Melsungen AG, Boehringer Ingelheim GmbH, Bristol-Myers-Squibb, CSL Behring GmbH, Celgene International II Sàrl, Daiichi Sankyo AG, Haemonetics, Instrumentation Laboratory (Werfen), LFB Biomédicaments, Merck Sharp & Dohme, PAION Deutschland GmbH, Pharmacosmos A/S, Pfizer AG, Pierre Fabre Pharma, Portola Schweiz GmbH, Roche Diagnostics International Ltd, Sarstedt AG & Co., Shire Switzerland GmbH, Tem International GmbH, Vifor Pharma, Vifor (International) AG, Zuellig Pharma Holdings. DRS's academic department is receiving grant support from the Swiss National Science Foundation, the Swiss Society of Anesthesiology and Reanimation (SGAR), the Swiss Foundation for Anesthesia Research, Vifor SA and Vifor (International) AG. DRS is co-chair of the ABC-Trauma Faculty, sponsored by unrestricted educational grants from Novo Nordisk Health Care AG, CSL Behring GmbH, LFB Biomédicaments, and Octapharma AG. <b>EJO</b> reports grants from Zurich University, during the conduct of the study. As part of the DO-HEALTH independent and investigator-initiated clinical trial, <b>HABF</b> reports as the PI of the DO-HEALTH trial, grants from European Commission, from University of Zurich, from NESTEC, from PFIZER Consumer Healthcare, from Streuli Pharma, plus nonfinancial support from DSM Nutritional Products and nonfinancial support from Roche Diagnostics. Further, Prof. Bischoff-Ferrari reports speaker fees from Wild, Pfizer, Vifor, Mylan, Roche Diagnostics, and independent and investigator-initiated grants from Pfizer and from Vifor. All other authors declare no competing interests.
: The Cantonal Ethical Committee of the Canton of Zurich approved this ancillary analysis (BASEC N° 2018–01755).
: Informed consent was obtained from all individual participants included in the study.